发明名称 |
Antisense modulation of GCGR expression |
摘要 |
Provided herein are methods, compounds, and compositions for reducing expression of GCGR mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate metabolic disease, for example, diabetes, or a symptom thereof. |
申请公布号 |
US9404114(B2) |
申请公布日期 |
2016.08.02 |
申请号 |
US201414484638 |
申请日期 |
2014.09.12 |
申请人 |
Ionis Pharmaceuticals, Inc. |
发明人 |
Freier Susan M.;Bhanot Sanjay |
分类号 |
C07H21/02;C07H21/04;A61K31/70;C12N15/113;C12Q1/68;A61K31/711 |
主分类号 |
C07H21/02 |
代理机构 |
Knobbe, Martens, Olson & Bear LLP |
代理人 |
Knobbe, Martens, Olson & Bear LLP |
主权项 |
1. A compound comprising a modified oligonucleotide 17 to 30 linked nucleosides in length and having a nucleobase sequence comprising the sequence of SEQ ID NOs: 17, 31, 81, 82 or 85, wherein said modified oligonucleotide is complementary to SEQ ID NO: 2, and wherein said modified oligonucleotide comprises at least one modified internucleoside linkage. |
地址 |
Carlsbad CA US |